• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锰配合物基 MRI 造影剂的研究进展:创新、设计策略及未来方向。

Advancements in manganese complex-based MRI agents: Innovations, design strategies, and future directions.

机构信息

School of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen 518055 China.

Education Center and Experiments and Innovations, Harbin Institute of Technology, Shenzhen 518055, China.

出版信息

Drug Discov Today. 2024 Sep;29(9):104101. doi: 10.1016/j.drudis.2024.104101. Epub 2024 Jul 15.

DOI:10.1016/j.drudis.2024.104101
PMID:39019428
Abstract

This review focuses on the advancements in manganese (Mn) complex-based magnetic resonance imaging (MRI) agents for imaging different diseases. Here we emphasize the unique redox properties of Mn to deliver innovative MRI contrast agents, including small molecules, nanoparticles (NPs), metal-organic frameworks (MOFs), and polymer hybrids. Aspects of their rational design have been discussed, including size dependence, morphology tuning, surface property enhancement, etc., while also discussing the existing challenges and potential solutions. The present work will inspire and motivate scientists to emphasize MRI-guided applications and bring clinical success in the coming years.

摘要

这篇综述重点介绍了基于锰(Mn)配合物的磁共振成像(MRI)造影剂在不同疾病成像方面的最新进展。文中强调了 Mn 的独特氧化还原性质在提供创新 MRI 造影剂方面的作用,包括小分子、纳米粒子(NPs)、金属有机骨架(MOFs)和聚合物杂化材料。本文还讨论了这些造影剂的合理设计,包括尺寸依赖性、形态调谐、表面性能增强等方面,同时也讨论了当前存在的挑战和潜在的解决方案。本工作将激发和激励科学家们重视 MRI 引导的应用,并在未来几年带来临床成功。

相似文献

1
Advancements in manganese complex-based MRI agents: Innovations, design strategies, and future directions.锰配合物基 MRI 造影剂的研究进展:创新、设计策略及未来方向。
Drug Discov Today. 2024 Sep;29(9):104101. doi: 10.1016/j.drudis.2024.104101. Epub 2024 Jul 15.
2
Manganese complexes and manganese-based metal-organic frameworks as contrast agents in MRI and chemotherapeutics agents: Applications and prospects.锰配合物和基于锰的金属有机骨架作为 MRI 和化疗药物的造影剂:应用与前景。
Colloids Surf B Biointerfaces. 2022 May;213:112432. doi: 10.1016/j.colsurfb.2022.112432. Epub 2022 Mar 2.
3
Recent Advances in Metal-Organic Frameworks for Applications in Magnetic Resonance Imaging.金属有机框架在磁共振成像应用中的最新进展。
ACS Appl Mater Interfaces. 2022 Nov 16;14(45):50445-50462. doi: 10.1021/acsami.2c10272. Epub 2022 Oct 14.
4
Integrating Fluorinated Polymer and Manganese-Layered Double Hydroxide Nanoparticles as pH-activated F MRI Agents for Specific and Sensitive Detection of Breast Cancer.将氟化聚合物和锰层状双氢氧化物纳米粒子整合为 pH 激活的 F MRI 造影剂,用于特异性和灵敏性检测乳腺癌。
Small. 2019 Sep;15(36):e1902309. doi: 10.1002/smll.201902309. Epub 2019 Jul 22.
5
Zwitterionic Manganese and Gadolinium Metal-Organic Frameworks as Efficient Contrast Agents for in Vivo Magnetic Resonance Imaging.两性离子锰和钆金属-有机骨架作为体内磁共振成像的高效造影剂。
ACS Appl Mater Interfaces. 2017 Nov 29;9(47):41378-41386. doi: 10.1021/acsami.7b09608. Epub 2017 Nov 16.
6
Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy.多功能 Hf/Mn-TCPP 金属有机框架纳米粒子用于三模态成像引导的 PTT/RT 协同癌症治疗。
Int J Nanomedicine. 2020 Oct 8;15:7687-7702. doi: 10.2147/IJN.S267321. eCollection 2020.
7
An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.一种用于在超顺磁性氧化铁纳米颗粒中进行可控锰(Mn(2+))取代以增强磁共振成像(MRI)对比度的水相方法。
Phys Chem Chem Phys. 2015 Feb 14;17(6):4609-19. doi: 10.1039/c4cp05122j.
8
The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.金属离子对作为磁共振成像对比剂的内源性黑色素纳米颗粒的影响。
Biomater Sci. 2020 Jan 1;8(1):379-390. doi: 10.1039/c9bm01580a. Epub 2019 Nov 15.
9
Mn(II) complexes of phenylenediamine based macrocyclic ligands as T-MRI contrast agents.基于苯二胺的大环配体的 Mn(II) 配合物作为 T1-MRI 对比剂。
J Inorg Biochem. 2022 Mar;228:111684. doi: 10.1016/j.jinorgbio.2021.111684. Epub 2021 Dec 4.
10
Mn(II) compounds as an alternative to Gd-based MRI probes.将 Mn(II) 化合物作为基于 Gd 的 MRI 探针的替代品。
Future Med Chem. 2019 Jun;11(12):1461-1483. doi: 10.4155/fmc-2018-0608. Epub 2019 Jul 12.

引用本文的文献

1
Advancing neuroimaging: novel manganese- and iron-based MRI contrast agents for cerebral ischemic diseases.先进的神经影像学:用于脑缺血性疾病的新型锰基和铁基磁共振成像造影剂
Discov Nano. 2025 Aug 18;20(1):142. doi: 10.1186/s11671-025-04325-4.
2
The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?锰基磁共振成像造影剂在癌症诊疗中的作用:到2025年我们处于什么水平?
Theranostics. 2025 Mar 15;15(9):4147-4174. doi: 10.7150/thno.108705. eCollection 2025.